As the demand for viral vectors in gene therapy increases and large-scale manufacturing becomes more crucial, improved downstream purification solutions are necessary to produce high yield and high purity vector products. Thermo Fisher Scientific’s POROS™ CaptureSelect™ AAVX affinity resin has demonstrated robust viral clearance across a range of AAV serotypes that are core to current gene therapy approaches.
Download now to learn how a series of viral clearance studies conducted using the POROS™ CaptureSelect™ AAVX affinity resin demonstrated a simplified and highly effective approach to optimizing AAV purification.
